Pharmaceuticals Business Investment Opportunity in Mathura, India

- Contract manufacturer of antibiotic tablets, capsules, and syrups.

- We have a huge capacity to manufacture the Potassium Clavulanate section and last year's turnover was INR 7 crore.

- We can do more than INR 25 crore turnover but looking for working capital and some investments.

- Production capacity (daily):

• 20 lakh tablets.

• 20,000 dry syrups.

• 5 lakh capsules.

- The plant has 50 regular employees and about 50 contract workers.

- The investor gets a 50% share in this unit. This means they get a 50% share of all the assets in this unit.

- We as a group have 5 other units and have registered this specific unit as a separate legal entity.

We are a contract manufacturer for more than 200 marketing companies. We manufacture:

- WHO-GMP beta-lactam tablets.

- Capsules.

- Dry syrups.

- Other medicines.

Our top-selling products are antibiotics like beta-lactam tablets.

Tangible assets:

- 1,000 sq. m. of land worth INR 25,000 per sq. m. (99-year leasehold that can easily be converted into freehold)

- Plant, machinery, and fixtures worth INR 4 crore.

Intangible assets:

- WHO-GMP certification.

99-year leasehold land facility of 1,000 sq. m. in UPSIDC, Kosi Kotwan north of Mathura. The facility is double floor, RCC-constructed, and has partitions of puff panels as per FDA Guidelines.

From Canara Bank, we have a term loan of INR 1.5 crore, an OD of INR 1 crore, and some creditors which are our suppliers.

This unit is registered as a proprietorship.